Substance use, Unlike Dolutegravir, is Associated with Mood Symptoms in People Living with HIV

Contradictory data have been reported concerning neuropsychiatric side effects of the first-line antiretroviral drug dolutegravir, which may be partly due to lack of control groups or psychiatric assessment tools. This dataset report BIS-11, DASS-42, MATE-Q scores of 194 people living with HIV receiving dolutegravir-containing treatment (82/194) or alternative treatment (112/194).

The results from this database have been published and are available at:

Van de Wijer, L., et al., Substance use, Unlike Dolutegravir, is Associated with Mood Symptoms in People Living with HIV. AIDS Behav, 2021. https://doi.org/10.1007/s10461-021-03272-2

Identifier
DOI https://doi.org/10.17026/dans-zs7-4htw
PID https://nbn-resolving.org/urn:nbn:nl:ui:13-vs-6hep
Metadata Access https://easy.dans.knaw.nl/oai?verb=GetRecord&metadataPrefix=oai_datacite&identifier=oai:easy.dans.knaw.nl:easy-dataset:260337
Provenance
Creator Wijer, L. van de; Heijden, W.A. van der
Publisher Data Archiving and Networked Services (DANS)
Contributor Radboud University
Publication Year 2021
Rights info:eu-repo/semantics/openAccess; License: http://creativecommons.org/licenses/by/4.0; http://creativecommons.org/licenses/by/4.0
OpenAccess true
Representation
Resource Type Dataset
Format .pdf; .ods; .txt; .xml
Discipline Life Sciences; Medicine; Psychology; Social and Behavioural Sciences